Skip to main content
ByMarch 26, 2026~20 min read

Jeen Technologies 2025: Orders Are Running Ahead, But Revenue Still Hasn't Proved This Is a Software Company

Jeen is showing sharp momentum in orders and customer logos, but 62% of revenue still comes from services, most of the reported order base is not binding, and the 2026 target relies partly on revenue that is not yet backed by work orders. The story is interesting, but it is still a proof year commercially and financially.

Getting To Know The Company

Jeen Technologies is not a mature software company that came public in order to accelerate sales. It is a very young GenAI operation that began inside One’s data division, moved into a dedicated company in July 2024, and was then injected into Micronet’s public shell in May 2025. What already works is its ability to get in front of large organizations, sell secure cloud or on-prem deployments, and build a list of customers, tenders, and commercial threads that most companies at this stage do not have. The active bottleneck is different: turning that traction into recognized, recurring, and profitable revenue before cost buildout, international expansion, and dilution consume too much of the value on the way.

That is exactly the point that is easy to miss on a fast read. The 2026 headlines look strong: NIS 19.4 million of expected orders at the end of 2025, NIS 64.7 million near the report date, and a NIS 61 million revenue target for 2026. But the company itself makes clear that these figures are not binding backlog under the regulations. As of December 31, 2025, only NIS 6.7 million of that amount was tied to work orders already received, while NIS 12.7 million came from signed statements of work that were not yet backed by work orders. Near the report date, the gap widened further: NIS 10.8 million in actual work orders versus NIS 53.9 million in signed SOWs without work orders.

The current economics also do not yet look like a clean software model. In 2025, 62% of revenue came from professional services and only 38% from licenses. ARR rose to NIS 3.683 million, but the recurring base is still materially smaller than the services layer, while the company has already built a heavy operating envelope around sales, management, and development. So the key question is not whether enterprise AI demand exists. It clearly does. The real question is how much of that demand will become recurring, software-quality revenue in time, without scale continuing to run through more human delivery hours.

From a market screen perspective, this is still a small-cap proof story. On the last synced trade date, daily trading value was about NIS 648 thousand, and there is no meaningful short-interest data to add an outside read. Even the balance sheet, which looked clean at year-end with NIS 29.1 million in cash, becomes less comfortable under an all-in cash-flexibility lens: by the end of February 2026, cash had already declined to about NIS 23 million, including about NIS 4.3 million of pledged deposits, mostly tied to office rent. In practice, the freely usable cushion is smaller than the headline number on the balance sheet.

LayerKey figureWhy it matters
Current revenue engineNIS 5.977 million from services versus NIS 3.695 million from licensesThe company still relies mainly on delivery rather than a clean licensing engine
Recurring baseARR of NIS 3.683 million in December 2025There is a growing recurring layer, but it is still small versus the full cost envelope
Order qualityNIS 19.4 million at year-end 2025 and NIS 64.7 million near the report date, with most of it in signed SOWs without work ordersThe commercial story is real, but the quality and commitment level of the numbers are mixed
Cost structureR&D of NIS 5.31 million, sales and marketing of NIS 4.089 million, and G&A of NIS 9.184 millionJeen built a growth platform early, before revenue reached scale
Balance-sheet flexibilityNIS 29.1 million cash at year-end 2025, about NIS 23 million at end-February 2026 including NIS 4.3 million pledgedThere is no bank debt, but there is also not much room for execution mistakes
2025 revenue mix
What really makes up the reported order base

Events And Triggers

A transition year in capital structure and control

First trigger: 2025 was an aggressive year of corporate and capital-structure rebuilding. In May, the merger was completed and 13.57 million shares were allocated to Jeen AI shareholders. Later in the year, another 8.05 million shares were allocated in July and 10.04 million more in August. This turned a young private activity into a public company almost overnight, strengthened the cash position, but also dramatically changed the equity base and dilution profile.

Second trigger: In August 2025 the company also completed a private placement of about NIS 23 million in exchange for 4.95 million shares, together with 3.59 million options at a NIS 6.5 exercise price. That was clearly positive from a funding perspective, but it is also a reminder that growth is currently being financed with equity, not by a self-funding operating model. The company explicitly says that continued development depends both on reaching profitability and, if needed, on raising additional financing in the future.

Third trigger: The NIS 17.332 million listing expense distorted the bottom line in 2025. This was a one-time, non-cash expense, so it would be wrong to read the annual loss only through that line. Still, even after stripping it out, the company posted an operating loss of NIS 12.681 million. In other words, the accounting item explains part of the headline, but not the core issue.

Early 2026 orders are real, but they are not all equal

Fourth trigger: At the end of January 2026 the company reported another win in a National Digital Directorate tender, worth about NIS 1 million over up to 12 months. The size is not the main point. The more important read is continuity: Jeen continues to enter through a government channel that requires adaptation, security, and delivery discipline.

Fifth trigger: In mid-March 2026, Jeen Defense received an immediate work order from a strategic client worth about NIS 4.3 million, plus optional components that could reach up to another NIS 45 million over 24 months. This is exactly the kind of headline the market likes, but it needs to be read carefully. The NIS 4.3 million is concrete. The additional NIS 45 million is optional and subject to the client’s discretion. The agreement also includes a royalty mechanism in certain cases involving future sales of knowledge or a change of control in Jeen Defense. So this is real commercial reinforcement, not locked backlog.

Sixth trigger: On March 25, 2026, Jeen signed a three-year agreement with one of Israel’s three largest healthcare bodies, with a total value of about NIS 9.1 million including VAT and an initial work order of about NIS 2.3 million. This is a higher-quality signal because it is a multi-year agreement. But even here there is an important nuance: the company states that part of the services, about NIS 1.4 million including VAT, had already been performed in prior months as part of sales efforts. So part of the “new sale” is also delayed monetization of earlier pre-sales work.

EventScaleQuality of certaintyWhy it matters
Jeen AI merger into Micronet13.57 million shares at completion and another 18.09 million in follow-on allocationsCertain and completedTurned a young activity public, but also created a new equity and dilution base
August 2025 private placementAbout NIS 23 million, 4.95 million shares and 3.59 million optionsCertain and completedBought time and cash, but did not solve the profit model
National Digital Directorate tenderAbout NIS 1 million over up to 12 monthsMedium, depends on actual orderingStrengthens government penetration but does not move the story by itself
Jeen Defense orderNIS 4.3 million immediate plus up to NIS 45 million optionalMixedSupports the 2026 narrative, but most of the upside is still non-binding
Healthcare agreementAbout NIS 9.1 million over 3 years, first order about NIS 2.3 millionHigher qualityShows the company beginning to move from pilot-style work into multi-year contracts

International expansion and the partner channel are still more framework than numbers

During 2025 the company established subsidiaries in the UK and the US, and also created Jeen Defense for the defense market. But in the audited statements it says the impact of the foreign subsidiaries and Jeen Defense was not material in 2025. That matters because the investor presentation already frames 2026 around regional activity centers in Singapore, London, and San Francisco, an active partner network, more than 20 partners in process, and even targeted M&A. That picture may eventually become a growth engine. At year-end 2025, it is still much more strategic framing than audited economic base.

Efficiency, Profitability, And Competition

The central point here is that Jeen still sells a solution, not yet a normalized software engine. That is not necessarily a negative at this stage, but it does change how margins and growth should be interpreted. A reader who focuses only on the rise in orders or on ARR may think this is already a software company with a clear SaaS shape. In practice, as of 2025, a large part of the business still runs through development, customization, implementation, support, and expansion work.

Commercial activity accelerated in the second half, but so did the loss envelope

There is also an important comparability point. The company explains that in the early period it classified part of service-related development costs according to their nature, while from 2025 onward customer-service-related costs were classified more directly into cost of sales. That means a simple gross-margin comparison between 2024 and 2025 does not produce a clean read of structural improvement. The 2025 gross margin, about 61%, looks respectable on paper, but it still sits on a mix where services are larger than licenses and where the cost classification itself changed.

What matters more is the relationship between revenue growth and cost buildout. R&D came to NIS 5.31 million, but that was after capitalizing NIS 2.65 million of development costs. In other words, the real product-build effort absorbed by the system was larger than the reported expense line alone. Sales and marketing reached NIS 4.089 million, while G&A reached NIS 9.184 million. This is not the envelope of a business already showing operating leverage. It is the envelope of a company building infrastructure ahead of expected scale.

The tension between product and services also shows up in ARR. The company emphasizes that most customers are ARR customers, and ARR itself grew from NIS 1.295 million in December 2024 to NIS 3.683 million in December 2025. That is fast growth. But total 2025 revenue was NIS 9.672 million, and only NIS 3.695 million of that came from licenses. The recurring engine exists, but it is still not large enough to define the whole business.

ARR: the recurring base is still small, but growing quickly

Concentration matters as well. Three material customers accounted for 25%, 19%, and 10% of 2025 revenue. On the positive side, the names disclosed across the report and the presentation, Isracard, Direct Insurance, Mizrahi Tefahot, Maccabi, Israel Aerospace Industries, Ormat, the National Digital Directorate, show that the product is getting into serious organizations. On the negative side, this is still a concentrated revenue base, so expansion at existing clients is both a growth engine and a source of dependency.

Concentration layer2025 evidenceWhy the identity matters
Material client 125% of revenueProves meaningful penetration, but creates real dependence on a single client
Material client 219% of revenueStrengthens the quality of the logo base, but does not yet diversify risk enough
Material client 310% of revenueEven after three major clients, the revenue base is still not broad
Financial sector34% of revenueA sector with clear need for secure AI, but also with long buying cycles and regulation
Defense and government19% of revenueProvides institutional credibility, but tends to be slower and budget-dependent
Pharma19% of revenueShows sector breadth, but still not deep enough diversification

Against that backdrop, competition is not light. The company itself names Microsoft Copilot, IBM WatsonX, H2O.ai, and Palantir among the competitive set. Jeen’s edge is in a model-agnostic architecture, security, deployment flexibility, and enterprise customization. The downside is just as clear: major vendors already sit deeply inside the client environment with stronger distribution, brand, and installed infrastructure. Jeen therefore needs to win in cases where secure deployment, on-prem flexibility, and customization really justify choosing a much younger supplier.

Cash Flow, Debt, And Capital Structure

There is no bank debt here. That is the positive part. But it also means equity and cash are carrying almost the full weight of the growth experiment. To understand 2025 correctly, it is necessary to separate the profit-and-loss picture from the all-in cash-flexibility picture, meaning how much cash is actually left after all real uses of cash.

The company used about NIS 12.791 million in operating cash during 2025 and another NIS 3.649 million in investing cash, mainly capitalized development costs of NIS 2.65 million and fixed-asset purchases. Against that, it generated NIS 45.601 million from financing activity, mainly from the merger, equity issuance, and related capital inflows. Without that financing layer, the year would have looked far less comfortable.

2025 cash picture

That is why it is not enough to say “the balance sheet is strong.” Yes, as of December 31, 2025, the company had NIS 34.743 million of current assets against NIS 4.549 million of current liabilities, and working capital surplus of NIS 30.194 million. There are no bank loans, no material supplier dependency, and even finance income from deposits. But the real read is that this balance was built with external capital, not by an operating model that already funds itself.

The gap becomes sharper when moving into February 2026. The company says cash stood at about NIS 23 million as of February 28, including about NIS 4.3 million of pledged deposits, mostly used to secure office rent. If that less-flexible layer is stripped out, accessible cash falls toward roughly NIS 18.7 million. For a company entering a growth year with international expansion, hiring, and market development, that is already a number that demands discipline.

There is also a quieter equity cost. At year-end 2025 there were 5.154 million employee and management options outstanding, together with another 3.594 million options granted to investors in the private placement. Together, that is potential dilution of about 17.8% relative to the existing share base. Not all of it will vest or be exercised, but it does mean Jeen’s growth model currently depends on both equity financing and equity compensation. Investors cannot ignore that when reading the growth story.

Outlook

First finding: the NIS 61 million 2026 revenue target is not built only on current orders. The company explicitly says the forecast also includes expected revenue for which neither a work order nor a statement of work has yet been signed. That does not automatically make the target unreasonable. It does mean the target is broader than the committed base visible today.

Second finding: even after the March jump in expected orders, only NIS 37.18 million of the updated base is scheduled for recognition during 2026. In other words, about NIS 23.82 million, roughly 39% of the NIS 61 million target, still needs to come from sources beyond the order schedule already disclosed.

Third finding: a meaningful part of the 2026 story sits on Jeen Defense, while the company itself says Jeen Defense and the foreign subsidiaries had immaterial impact on the 2025 audited statements. That is not a contradiction, but it is clearly a demand for proof.

Fourth finding: the healthcare agreement is a better-quality signal than part of the broader order base, because it is signed for three years. But even there, the first order includes work that had already been delivered as part of pre-sales efforts. That improves visibility, but does not by itself prove that the next layer of scale will arrive without heavy sales effort.

Fifth finding: the company is building 2026 through partners, international activity, and even targeted M&A possibilities. Those can widen market access, but they can also turn 2026 into an expensive build year before the domestic core has fully proved repeatable economics.

The gap between the visible revenue base and the 2026 target

If the next year needs a name, it is not a clean breakout year. It is a proof year. The company has already shown that it has a product that resonates with large organizations and that it can generate traction in government, defense, financial services, and healthcare. But it has not yet shown that the revenue model can scale faster than the sales, management, and development envelope around it.

What has to happen for the target to move from bold statement to something the market can start underwriting? First, statements of work need to convert into binding work orders, especially in the second half of 2026. Second, a larger part of revenue needs to come through licensing and ARR rather than implementation, customization, and support hours. Third, Jeen Defense needs to move from headline engine to real line-item revenue. Fourth, international activity and the partner channel need to start generating deals, not only pipeline.

There is also a very specific near-term market-reading issue. The NIS 64.7 million number is highly attractive on first read, but anyone reading more closely will focus on composition. If the next reports show real conversion of SOWs into orders, a higher licensing mix, and contracts entering live delivery, the market read can improve quickly. If not, 2026 may be read as a year in which the headlines ran ahead of revenue recognition.

Risks

Order quality and revenue recognition

The first risk is also the main one: a large share of what the company presents is not binding backlog. The company says so itself. That means any delay in client decision-making, any rollout slippage, or any change in internal priorities at large organizations can push revenue across periods even while the headline number looks unchanged.

A revenue mix that still runs through people

The second risk is the quality of scale. As long as 62% of revenue comes from professional services, growth cannot be read as clean software growth. The company itself says platform-selling capacity is not constrained, but additional modules and client service are limited by the human resources it employs. So 2026 may be constrained not by demand, but by delivery.

Customer concentration and dependence on a few key threads

Three material customers represented 54% of revenue. That is still high concentration. In addition, a meaningful part of the 2026 narrative rests on a small number of specific threads: healthcare, defense, government, and expansion inside existing accounts. If one of those slows, the proof base for the year weakens quickly.

Cash pressure and dilution

The fourth risk is not debt, but cash burn versus the pace of proof. The company entered 2026 with a decent cash balance, but the decline from about NIS 29.1 million at year-end to about NIS 23 million by end-February, together with the NIS 4.3 million pledged layer, shows that the time bought by the financing is not unlimited. If revenue conversion slips, the capital market could become an active funding source again, with further dilution.

Competition and the move abroad

The fifth risk is competitive intensity. On one hand, Jeen has a clear edge in use cases that require secure deployment, model flexibility, and on-prem control. On the other hand, the market is populated by giants like Microsoft and IBM that are already deeply embedded at the client. Add international expansion that has not yet proved an economic base, and the result is a mix of high potential with meaningful execution risk.


Conclusions

Jeen Technologies ends 2025 with two things that are clearly real: commercial demand that is starting to become visible, and a balance sheet that was cleaned up through the merger and the capital raise. That is the positive base. The core blocker is that the company has still not shown that this demand rolls into software-quality revenue rather than an expensive service-heavy model with strong headlines. In the short to medium term, the market will try to answer one question: will 2026 bring real order conversion, or just another layer of pipeline?

Current thesis in one line: Jeen has already proved that its product can reach serious enterprise customers, but it has not yet proved that the economics of the business can scale faster than cost, dilution, and cash pressure.

Compared with the starting point in 2024, what has really changed is that there is now a customer base, ARR, and a live opportunity set that look like a real company rather than a project. What has not changed enough is the economic stage: even in 2025 the company remained far from a profitable model, and the forward target still depends on converting intention into commitment.

The strongest counter-thesis is that this is exactly what a young enterprise-AI company should look like: services open the doors, licenses expand later, ARR rises quickly, and the cost base is pulled forward deliberately in order to capture the market before the competitive landscape settles. That is a reasonable counter-thesis. The problem is that it now needs numerical proof, not only story quality.

What could change the market read is less about adding another logo and more about improving the quality of revenue. If the coming reports show SOWs turning into orders, a higher licensing mix, and a calmer cash profile, the company can start to be read as a software name in growth. If not, it will remain an AI company with an impressive service layer, but an expensive one.

Why this matters is simple: in enterprise AI there is no shortage of decks and no shortage of targets. What is scarce is proof that someone can turn rollout, customization, and customer logos into recurring revenue that is actually accessible to shareholders.

MetricScoreExplanation
Overall moat strength3.0 / 5There is real edge in enterprise customization, security, and secure deployment, but the moat is not yet proven against global incumbents
Overall risk level4.0 / 5Order quality, cash burn, customer concentration, and potential dilution make this a demanding proof year
Value-chain resilienceMediumThere is no material supplier dependence, but revenue still depends heavily on delivery capacity and hiring
Strategic clarityMediumThe direction is clear, secure enterprise AI, defense, healthcare, international expansion, and partners, but the gap between vision and execution remains wide
Short-interest readData unavailableThere is no usable short-interest data, so there is no external signal either confirming or contradicting the fundamentals

Over the next 2 to 4 quarters Jeen needs to show three things: real conversion of SOWs into binding work orders, a rising share of licensing and ARR inside revenue, and stabilization in cash burn after all real uses of cash. What would weaken the read further is another report in which orders keep growing, but recognized revenue and cash still fail to close the gap.

Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.

The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.

The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.

Found an issue in this analysis?Editorial corrections and sharp feedback help keep the coverage honest.
Report a correction
Follow-ups
Additional reads that extend the main thesis